^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    simmitinib (SYHA1817)

    i
    Associations
    News
    Trials
    Company:
    CSPC Pharma
    Drug class:
    FGFR inhibitor, VEGFR-2 inhibitor, CSF-1R inhibitor
    Related drugs:
    Associations
    News
    Trials